Zebrafish knockout models of atxn1a, atxn1b, and atxn1l reveal distinct and shared phenotypic and transcriptomic alterations

This study establishes the first zebrafish knockout models for the ataxin-1 family genes (atxn1a, atxn1b, and atxn1l), revealing that while they share essential roles in early development and neuroimmune regulation, they also exhibit distinct, paralog-specific impacts on sensorimotor behavior and retinal signaling.

The Gist

Imagine the human body as a massive, bustling city. Inside this city, there are specific construction crews responsible for keeping the roads smooth, the lights working, and the emergency services ready. One of the most important foremen in this city is a protein called ATXN1.

For decades, scientists have known that if this foreman gets "glitched" (due to a genetic mutation), it causes a devastating disease called Spinocerebellar Ataxia type 1 (SCA1). This glitch makes the foreman toxic, causing the city's "traffic lights" (neurons) to fail, leading to a loss of balance and coordination.

However, scientists have been puzzled: What does the healthy, normal foreman actually do when he isn't glitched? And what happens if we accidentally remove the foreman entirely?

To answer this, a team of researchers built a miniature, transparent city: the Zebrafish. They created three different versions of these fish, each missing a different "foreman" gene: atxn1a, atxn1b, and atxn1l. Think of these as three slightly different blueprints for the same job, but with distinct personalities.

Here is what they discovered, translated into everyday terms:

1. The "Baby" Fish Struggle to Survive

When the researchers removed these genes, the baby fish (larvae) had a harder time getting started.

• The Analogy: Imagine trying to build a house without a foundation. Many of the baby fish didn't survive the first day. Those that did were a bit smaller than their healthy neighbors.
• The Takeaway: These genes are essential for early development. You can't just turn them off without consequences; the body needs them to grow properly.

2. The "Light Switch" Mystery

The researchers put the baby fish in a tank and switched the lights on and off to see how they swam.

• The "atxn1b" and "atxn1l" Fish: These fish were like tired hikers. Whether the lights were on or off, they just didn't want to move much. They were generally sluggish.
• The "atxn1a" Fish: These fish were the odd ones out. They swam just fine in the dark, but the moment the lights turned on, they froze or swam very slowly.
• The Analogy: It's like having a security camera that works perfectly at night but gets blinded by the sun. The atxn1a gene seems to be the specific "sunscreen" or "light filter" for the fish's movement system. When it's missing, bright light confuses them.

3. The Adult "Anxiety" Test

As the fish grew up, the researchers watched them swim in a new tank. Healthy fish usually stick to the bottom of the tank (like shy people hiding in a corner).

• The Finding: The fish missing the atxn1a gene were the most adventurous (or perhaps reckless). They spent a lot of time swimming near the surface, ignoring the "safety" of the bottom.
• The Takeaway: This suggests these genes help regulate "anxiety" or caution in the brain. Without them, the fish might be less afraid, but perhaps less aware of danger.

4. The "City Blueprint" (Genetic Analysis)

The researchers took a snapshot of the fish's genetic "instruction manuals" (RNA) to see what was different.

• The Shared Problem: All three groups of fish had trouble with their "immune system" and "inflammation" controls. It's like the city's fire department and police force were understaffed. This is exciting because it links these genes to other diseases like Alzheimer's and Multiple Sclerosis, where inflammation plays a huge role.
• The Unique Problem: The atxn1a fish had a specific glitch in their "visual processing" manual. Their genes for seeing light were turned up too high. This perfectly explained why they froze when the lights turned on—their eyes were screaming "TOO BRIGHT!" and their brains couldn't handle the signal.

Why Does This Matter?

Scientists are currently developing drugs to lower the levels of the ATXN1 protein to stop the "glitched" version from causing SCA1. But this study is a warning label: If you turn down the volume on ATXN1 too much, you might accidentally turn off the "healthy" version too.

The Big Picture:
This paper is like finding out that while a specific tool causes a problem when it's broken, that same tool is also vital for keeping the city's lights on and the police force active. By studying these tiny fish, scientists can now design better treatments that fix the "glitch" without accidentally turning off the "healthy" foreman, ensuring the city stays safe and functional.

Technical Summary

1. Problem Statement

Spinocerebellar ataxia type 1 (SCA1) is a progressive neurodegenerative disorder caused by a polyglutamine (polyQ) expansion in the ATXN1 gene. While the toxic gain-of-function mechanisms of mutant ATXN1 are well-studied, the normal physiological roles of wild-type ATXN1 and its paralog ATXN1L remain incompletely understood. This knowledge gap is critical because emerging therapeutic strategies for SCA1 (e.g., antisense oligonucleotides) aim to lower ATXN1 expression, potentially affecting the wild-type protein. Furthermore, ATXN1 variants are linked to increased risks for Alzheimer's disease and multiple sclerosis. Existing models (primarily mouse) have limitations, and there was a lack of zebrafish models specifically designed to study the loss-of-function physiology of the three zebrafish orthologs: atxn1a, atxn1b, and atxn1l.

2. Methodology

The authors employed a multi-modal approach combining CRISPR/Cas9 genome editing, behavioral phenotyping, and transcriptomics:

• Model Generation:
  • Generated homozygous knockout (KO) zebrafish lines for atxn1a, atxn1b, and atxn1l using CRISPR/Cas9.
  • Targeted the first coding exon of each gene to induce frameshift mutations (e.g., 14 bp deletion in atxn1a, 1 bp deletion in atxn1b, 4 bp deletion in atxn1l).
  • Validated mutations via Sanger sequencing and RNA-seq.
• Phenotypic Characterization:
  • Larval Stage (5 days post-fertilization, dpf): Assessed survival rates, hatching efficiency, and body length. Conducted high-throughput locomotor tracking using the DanioVision system under two light-dark paradigms (short: 10 min cycles; long: 1 hour cycles).
  • Adult Stage: Evaluated behavior at 8, 12, and 16 months using:
    • Novel Tank Test: Measured zone occupancy (top/middle/bottom) to assess anxiety-like behavior and exploration.
    • Swim Tunnel Assay: Measured swimming endurance and performance against increasing water currents.
• Transcriptomic Analysis:
  • Performed RNA-seq on pooled larvae (20 per group) at 5 dpf.
  • Identified Differentially Expressed Genes (DEGs) using DESeq2 (FDR < 0.05, |log2FC| > 1).
  • Conducted Gene Ontology (GO) enrichment analysis using DAVID and danRerLib.
  • Applied Weighted Gene Co-expression Network Analysis (WGCNA) via CEMiTool to identify gene modules correlated with specific KO genotypes.

3. Key Contributions

• First Zebrafish KO Models: Established the first comprehensive set of zebrafish knockout models for all three atxn1 family genes (atxn1a, atxn1b, atxn1l).
• Paralog-Specific Phenotyping: Demonstrated that while these paralogs share some functions, they exhibit distinct, non-redundant roles in development and behavior.
• Mechanistic Link to Phenotype: Connected specific behavioral deficits (e.g., light-dependent locomotion) to specific transcriptomic alterations (e.g., phototransduction pathways).
• Neuroimmune Insights: Identified shared downregulation of innate immune and leukotriene biosynthetic pathways, suggesting a role for ATXN1-family genes in early neuroimmune regulation.

4. Key Results

A. Developmental and Survival Deficits

• Survival: All KO lines showed significantly reduced survival compared to Wild-Type (WT), with the majority of mortality occurring within the first 24 hours.
• Hatching: atxn1a KO embryos exhibited a significantly delayed hatching rate at 2 dpf compared to WT.
• Growth: All KO larvae had statistically significant reductions in body length at 5 dpf, with atxn1l KO showing the shortest length.

B. Behavioral Alterations

• Larval Locomotion (5 dpf):
  • atxn1a KO: Exhibited a unique light-dependent locomotor deficit. They moved significantly less than WT only during light phases, while movement in the dark was comparable to WT.
  • atxn1b and atxn1l KO: Displayed global hypoactivity, traveling shorter distances than WT in both light and dark conditions.
• Adult Behavior:
  • Novel Tank Test: A gradient of severity was observed. atxn1a KO fish showed the earliest and most pronounced increase in time spent in the top zone (reduced anxiety-like behavior) at 8 months. atxn1b and atxn1l KOs showed similar but delayed phenotypes (significant only at 12–16 months).
  • Swim Tunnel: All KO lines showed reduced swimming performance at 12 months, with atxn1a KO performing the worst, indicating deficits in strength, endurance, or coordination.

C. Transcriptomic Alterations (5 dpf)

• Global Changes: Identified 1,265 total DEGs across the three lines. 249 genes were commonly dysregulated across all three KOs.
• Shared Pathways (Downregulated):
  • Leukotriene Biosynthesis: Significant downregulation of alox5 family genes and the lipoxygenase pathway.
  • Innate Immunity: Downregulation of complement pathway genes (c1r, c1s.2) and nos2a (inducible nitric oxide synthase).
  • Cell Differentiation: Upregulation of her4.3 (a Hes5 ortholog), suggesting suppression of neuronal differentiation.
• Paralog-Specific Findings:
  • atxn1a KO: Unique downregulation of irs2a (insulin signaling) and a gene module (M03) highly enriched for phototransduction genes (pde6a, pde6b). This provides a mechanistic explanation for the light-dependent locomotor deficit.
  • atxn1b KO: Enrichment of complement activation pathways and upregulation of sox4a (glial proliferation).
  • atxn1l KO: Strongest downregulation of apoea (lipoprotein metabolism).

5. Significance

• Therapeutic Safety: The study highlights that complete loss of ATXN1 function causes developmental and behavioral deficits, underscoring the risk of therapeutic strategies that non-specifically lower wild-type ATXN1.
• Disease Mechanisms: The shared suppression of innate immune pathways (leukotrienes, nitric oxide) and microglial migration genes (dock8) offers a new mechanistic link between ATXN1 loss and increased susceptibility to neuroinflammatory conditions like Multiple Sclerosis and Alzheimer's disease.
• Model Utility: These zebrafish models provide a robust, high-throughput platform for dissecting the specific contributions of ATXN1 paralogs to neurodevelopment, sensorimotor function, and retinal signaling, bridging the gap between mouse models and human disease.
• Specific Insight: The discovery of the atxn1a-specific phototransduction module suggests a previously unknown role for ATXN1 in visual processing and light-mediated behavior.